Cargando…

Role of TOPK in lipopolysaccharide-induced breast cancer cell migration and invasion

Inflammation has been known to be linked to invasion or metastasis of breast cancer, which has poor prognosis, although the regulatory mechanism remains to be undiscovered. Here we show that T-LAK cell-originated protein kinase (TOPK) mediates pro-inflammatory endotoxin lipopolysaccharide (LPS)-indu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Seol, Min-Ah, Park, Jung-Hwan, Jeong, Ji Heun, Lyu, Jungmook, Han, Seung Yun, Oh, Sang-Muk
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5522254/ https://www.ncbi.nlm.nih.gov/pubmed/28212583 http://dx.doi.org/10.18632/oncotarget.15360

Ejemplares similares

Phosphorylation of TOPK at Y74, Y272 by Src increases the stability of TOPK and promotes tumorigenesis of colon
por: Xiao, Juanjuan, et al.
Publicado: (2016)

PBK/TOPK Is a Favorable Prognostic Biomarker Correlated with Antitumor Immunity in Colon Cancers
por: Lee, Dong-Hee, et al.
Publicado: (2022)

PBK/TOPK mediates geranylgeranylation signaling for breast cancer cell proliferation
por: Dou, Xiaoyan, et al.
Publicado: (2015)

PBK/TOPK Expression Predicts Prognosis in Oral Cancer
por: Chang, Chin-Fang, et al.
Publicado: (2016)

PBK/TOPK Inhibitor Suppresses the Progression of Prolactinomas
por: Zhu, Kejing, et al.
Publicado: (2022)

TOPK and PTEN participate in CHFR mediated mitotic checkpoint()
por: Shinde, Swapnil R., et al.
Publicado: (2013)

Targeting PRPK and TOPK for skin cancer prevention and therapy
por: Roh, Eunmiri, et al.
Publicado: (2018)

PBK/TOPK: A Therapeutic Target Worthy of Attention
por: Han, Ziping, et al.
Publicado: (2021)

Comprehensive Physicochemical Characterization, In Vitro Membrane Permeation, and In Vitro Human Skin Cell Culture of a Novel TOPK Inhibitor, HI-TOPK-032
por: Eedara, Basanth Babu, et al.
Publicado: (2023)

PBK/TOPK: An Effective Drug Target with Diverse Therapeutic Potential
por: Huang, Hai, et al.
Publicado: (2021)

Metadherin Mediates Lipopolysaccharide-Induced Migration and Invasion of Breast Cancer Cells
por: Zhao, Yuhan, et al.
Publicado: (2011)

Overexpression of PBK/TOPK relates to poor prognosis of patients with breast cancer: a retrospective analysis
por: Qiao, Liang, et al.
Publicado: (2022)

PBK attenuates paclitaxel‐induced autophagic cell death by suppressing p53 in H460 non‐small‐cell lung cancer cells
por: Park, Jung‐Hwan, et al.
Publicado: (2020)

TOPK inhibits autophagy by phosphorylating ULK1 and promotes glioma resistance to TMZ
por: Lu, Hui, et al.
Publicado: (2019)

Potent anti‐myeloma activity of the TOPK inhibitor OTS514 in pre‐clinical models
por: Stefka, Andrew T., et al.
Publicado: (2019)

Sestrin2 inhibits YAP activation and negatively regulates corneal epithelial cell proliferation
por: Lee, Ji-Su, et al.
Publicado: (2020)

TOPK is highly expressed in circulating tumor cells, enabling metastasis of prostate cancer
por: Sun, Huimin, et al.
Publicado: (2015)

TOPK modulates tumour-specific radiosensitivity and correlates with recurrence after prostate radiotherapy
por: Pirovano, Giacomo, et al.
Publicado: (2017)

FYN/TOPK/HSPB1 axis facilitates the proliferation and metastasis of gastric cancer
por: Peng, SanFei, et al.
Publicado: (2023)

Overexpression of PBK/TOPK relates to tumour malignant potential and poor outcome of gastric carcinoma
por: Ohashi, Takuma, et al.
Publicado: (2017)

PBK/TOPK overexpression and survival in solid tumors: A PRISMA-compliant meta-analysis
por: Xu, Ming, et al.
Publicado: (2019)

T-LAK cell-originated protein kinase (TOPK): an emerging target for cancer-specific therapeutics
por: Herbert, Katharine J., et al.
Publicado: (2018)

Targeting TOPK sensitises tumour cells to radiation-induced damage by enhancing replication stress
por: Herbert, Katharine J., et al.
Publicado: (2020)

OTS964, a TOPK Inhibitor, Is Susceptible to ABCG2-Mediated Drug Resistance
por: Yang, Yuqi, et al.
Publicado: (2021)

Inhibiting ALK-TOPK signaling pathway promotes cell apoptosis of ALK-positive NSCLC
por: Xiao, Juanjuan, et al.
Publicado: (2022)

Erratum to: TOPK Activation Exerts Protective Effects on Cisplatin-induced Acute Kidney Injury
por: Zhang, Hui, et al.
Publicado: (2022)

Oncogenic roles of TOPK and MELK, and effective growth suppression by small molecular inhibitors in kidney cancer cells
por: Kato, Taigo, et al.
Publicado: (2016)

PBK/TOPK enhances aggressive phenotype in prostate cancer via β-catenin-TCF/LEF-mediated matrix metalloproteinases production and invasion
por: Brown-Clay, Joshua D., et al.
Publicado: (2015)

Ryk modulates the niche activity of mesenchymal stromal cells by fine-tuning canonical Wnt signaling
por: Jeong, Seon-Yeong, et al.
Publicado: (2020)

Effects of Ranibizumab, Bevacizumab, and Aflibercept on Senescent Retinal Pigment Epithelial Cells
por: Chae, Jae-Byoung, et al.
Publicado: (2018)

Targeting the COX2/MET/TOPK signaling axis induces apoptosis in gefitinib-resistant NSCLC cells
por: Xiao, Juanjuan, et al.
Publicado: (2019)

Genomic alterations of primary tumor and blood in invasive ductal carcinoma of breast
por: Bae, Ja Seong, et al.
Publicado: (2010)

T‐LAK cell‐originated protein kinase (TOPK) is a Novel Prognostic and Therapeutic Target in Chordoma
por: Thanindratarn, Pichaya, et al.
Publicado: (2020)

T‐LAK cell‐originated protein kinase (TOPK): an emerging prognostic biomarker and therapeutic target in osteosarcoma
por: Thanindratarn, Pichaya, et al.
Publicado: (2021)

Erratum: PBK/TOPK enhances aggressive phenotype in prostate cancer via β-catenin-TCF/LEF-mediated matrix metalloproteinases production and invasion
por: Brown-Clay, Joshua D., et al.
Publicado: (2016)

TOPK (T‐LAK cell‐originated protein kinase) inhibitor exhibits growth suppressive effect on small cell lung cancer
por: Park, Jae‐Hyun, et al.
Publicado: (2017)

TOPK promotes lung cancer resistance to EGFR tyrosine kinase inhibitors by phosphorylating and activating c-Jun
por: Li, Ying, et al.
Publicado: (2016)

TOPK/PBK is phosphorylated by ERK2 at serine 32, promotes tumorigenesis and is involved in sorafenib resistance in RCC
por: Sun, Huimin, et al.
Publicado: (2022)

TOPK mediates immune evasion of renal cell carcinoma via upregulating the expression of PD-L1
por: Li, Jinxin, et al.
Publicado: (2023)

PBK/TOPK inhibitor OTS964 resistance is mediated by ABCB1-dependent transport function in cancer: in vitro and in vivo study
por: Yang, Yuqi, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_880u6l9nokf4ea3mtvvc1fq4mq